glp-1 name What the NY Times Got Right — and What It Missed — About Drugs Comparing Ozempic, Wegovy and Other

Dual Incretin Mechanism Tirzepatide's unique dual-action mechanism activates both GIP and GLP-1 receptors, producing synergistic metabolic effects superior to single-pathway activation [2]

Schlee M, Hartmann G (2016) Discriminating self from non-self in nucleic acid sensing

Such references are made for informational purposes only and are not sponsored, authorized, or endorsed by, or otherwise affiliated with, the respective trademark owners

GLP-1 agonists, such as semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and GLP-1/GIP agonists such as tirzepatide (Mounjaro, Zepbound), work by mimicking the action of the GLP-1 and/or GIP hormones

The peptide works synergistically with conventional approaches to potentially compress healing timelines